Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) Director Walter S. Woltosz sold 18,121 shares of the stock in a transaction that occurred on Monday, August 29th. The stock was sold at an average price of $61.49, for a total transaction of $1,114,260.29. Following the completion of the sale, the director now owns 4,099,786 shares in the company, valued at $252,095,841.14. The transaction was disclosed in a filing with the SEC, which is available through this link.

Simulations Plus Stock Performance

Simulations Plus stock opened at $58.79 on Friday. The firm's fifty day moving average price is $58.96 and its 200-day moving average price is $49.96. The stock has a market cap of $1.19 billion, a P/E ratio of 103.13 and a beta of 0.42. Simulations Plus, Inc. has a fifty-two week low of $35.18 and a fifty-two week high of $67.59.

Simulations Plus (NASDAQ:SLP – Get Rating) last released its earnings results on Wednesday, July 6th. The technology company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.17 by $0.03. Simulations Plus had a net margin of 22.74% and a return on equity of 6.91%. The company had revenue of $14.96 million for the quarter, compared to analyst estimates of $14.33 million. During the same quarter last year, the firm earned $0.18 EPS. The firm's quarterly revenue was up 17.1% compared to the same quarter last year. On average, analysts predict that Simulations Plus, Inc. will post 0.64 earnings per share for the current year.

Simulations Plus Announces Dividend

Analysts Set New Price Targets

SLP has been the topic of several recent analyst reports. Craig Hallum increased their target price on shares of Simulations Plus from $55.00 to $60.00 and gave the stock a "buy" rating in a research note on Thursday, July 7th. TheStreet upgraded shares of Simulations Plus from a "c+" rating to a "b-" rating in a research report on Friday, July 22nd. Finally, Raymond James raised their price objective on shares of Simulations Plus from $54.00 to $70.00 and gave the company an "outperform" rating in a research report on Monday. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $65.00.

Hedge Funds Weigh In On Simulations Plus

Several institutional investors and hedge funds have recently made changes to their positions in the business. US Bancorp DE grew its holdings in shares of Simulations Plus by 3.8% during the 2nd quarter. US Bancorp DE now owns 4,330 shares of the technology company's stock valued at $214,000 after purchasing an additional 159 shares during the last quarter. New York State Teachers Retirement System grew its holdings in Simulations Plus by 3.2% in the 2nd quarter. New York State Teachers Retirement System now owns 6,518 shares of the technology company's stock worth $322,000 after acquiring an additional 200 shares during the last quarter. Texas Permanent School Fund grew its holdings in Simulations Plus by 2.1% in the 2nd quarter. Texas Permanent School Fund now owns 11,392 shares of the technology company's stock worth $562,000 after acquiring an additional 236 shares during the last quarter. Rhumbline Advisers grew its holdings in Simulations Plus by 0.5% in the 1st quarter. Rhumbline Advisers now owns 59,693 shares of the technology company's stock worth $3,043,000 after acquiring an additional 279 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Simulations Plus by 0.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 51,715 shares of the technology company's stock worth $2,551,000 after acquiring an additional 284 shares during the last quarter. Institutional investors own 72.51% of the company's stock.

Simulations Plus Company Profile

(Get Rating)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft.

See Also

• Get a free copy of the StockNews.com research report on Simulations Plus (SLP)
• Could Nike Stock be Oversold, but Still Overvalued?
• Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?
• Will Royal Caribbean's Broadband Partnership Drive Revenue?
• Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?
• DocuSign Has Important Issues to Address When it Reports Earnings

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.